Expression patterns of protein kinase C isoenzymes are characteristically modulated in chronic pancreatitis and pancreatic cancer

被引:45
作者
Evans, JD
Cornford, PA
Dodson, A
Neoptolemos, JP
Foster, CS
机构
[1] Univ Liverpool, Royal Liverpool Univ Hosp, Dept Pathol, Liverpool L69 3GA, Merseyside, England
[2] Univ Liverpool, Royal Liverpool Univ Hosp, Dept Surg, Liverpool L69 3GA, Merseyside, England
关键词
protein kinase C isoenzymes; pancreatic diseases; signaling pathways;
D O I
10.1309/BKPC9DX98R781B87
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
We immunohistochemically identified protein kinase C (PKC) isoenzymes and the receptor for activated C-kinase (RACK-1) in normal, chronically inflamed, and malignant pancreas specimens. Expression patterns were specific and consistent,for each microanatomic structure. In chronic pancreatitis, the expression patterns by epithelial cells were indistinguishable from those in normal pancreas. In the stroma, there was a gain of PKC-delta (P < .05) and loss of PKC-mu (P <. 0001). Expression in pancreatic duct carcinomas, compared with control normal minor ductular epithelial cells, revealed relative loss of PKC-epsilon (P <. 0001), PKC-iota (P = .005), and PKC-theta (P < .0001) but no gain in any isoenzyme. Compared with control normal major duct epithelial cells, the principal differences were a relative loss in PKC-gamma (P < .05) and a relative gain in PKC-beta (P < .05), PKC-iota (P < .05), and PKC-zeta (P < .005). The stroma adjacent to ductal carcinomas was characterized by prominent expression of PKC-mu and a gain in PKC-delta (P <. 0001) and PKC-zeta (P > .005). Ampullary carcinomas revealed a relative gain of PKC-iota (P < .05) and RACK-1 (P < .05). In the adjacent stroma was enhanced expression of PKC-delta (P <. 005) and PKC-gamma (P <. 001) and loss of PKC-mu (P <. 05). Specific changes in isoenzyme expression in stroma of chronic pancreatitis and in epithelial cells and stroma of ductal and ampullary pancreatic adenocarcinomas reflect specific modulation of intracellular signaling pathways that control critical homeostatic mechanisms.
引用
收藏
页码:392 / 402
页数:11
相关论文
共 64 条
[1]  
Akinaga S, 2000, ANTI-CANCER DRUG DES, V15, P43
[2]   PROTEIN KINASE-C AND T-CELL ACTIVATION [J].
BERRY, N ;
NISHIZUKA, Y .
EUROPEAN JOURNAL OF BIOCHEMISTRY, 1990, 189 (02) :205-214
[3]  
CALDAS C, 1994, CANCER RES, V54, P3568
[4]  
CHAMBERS TC, 1990, J BIOL CHEM, V265, P7679
[5]   THE MODULATION OF GROWTH BY HMBA IN PKC OVERPRODUCING HT29 COLON CANCER-CELLS [J].
CHOI, PM ;
WEINSTEIN, IB .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1991, 181 (02) :809-817
[6]   Protein kinase c isoenzyme patterns characteristically modulated in early prostate cancer [J].
Cornford, P ;
Evans, J ;
Dodson, A ;
Parsons, K ;
Woolfenden, A ;
Neoptolemos, J ;
Foster, CS .
AMERICAN JOURNAL OF PATHOLOGY, 1999, 154 (01) :137-144
[7]  
Cornford PA, 2000, CANCER RES, V60, P7099
[8]   PKC-δ is an apoptotic lamin kinase [J].
Cross, T ;
Griffiths, G ;
Deacon, E ;
Sallis, R ;
Gough, M ;
Watters, D ;
Lord, JM .
ONCOGENE, 2000, 19 (19) :2331-2337
[9]   Pharmacologic modulation of protein kinase C isozymes: The role of races and subcellular localisation [J].
Csukai, M ;
Mochly-Rosen, D .
PHARMACOLOGICAL RESEARCH, 1999, 39 (04) :253-259
[10]  
CUBILLA AL, 1975, CANCER RES, V35, P2234